Chronic functional constipation in young and middle age patients: delicate problem – delicate decision

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Constipation is a serious medical and social problem due to the widespread prevalence of this condition, a decrease in the quality of life and social activity of patients. For successful treatment of constipation, it is necessary to establish the causes leading to a violation of the stool in the patient. And this task is a priority for the doctor at the outpatient stage. A common gastroenterological pathology is functional constipation, for which no physiological, anatomical or iatrogenic origin can be identified. Constipation is a delicate problem, with the importance of «delicacy» being inversely proportional to the patient’s age. We conducted an express survey of 30 women aged 23 to 42 years, in which we asked them to rate on a five-point scale (1 – minimum, 5 – maximum) the convenience of using various forms of laxatives and their «delicacy» (lack of direct instructions for others if they have a constipation problem). Mineral water (4.8) and disposable filter bags (herbal tea – 4.0 points) received the highest average score. Next came tablets (3.3 points) and capsules (3.2 points). The least convenient respondents attributed drops (2.1 points) and powders for preparing a solution (1.9 points). The possibilities of natural mineral waters rich in magnesium sulfate in the treatment of constipation are considered. To date, three natural mineral waters rich in magnesium sulfate have been studied in randomized, double-blind, placebo-controlled clinical trials. Comparison of the effectiveness of the three studied mineral waters showed that Donat mineral water is more effective. The results of a randomized clinical trial of Donat Mg mineral water in the treatment of functional constipation, as well as the experience of its use in domestic studies demonstrating the effectiveness and safety of Donat Mg therapeutic mineral water in pediatric practice and in adult patients with functional constipation and other gastroenterological pathology.

Full Text

Restricted Access

About the authors

Dmitry I. Trukhan

Omsk State Medical University

Author for correspondence.
Email: dmitry_trukhan@mail.ru
ORCID iD: 0000-0002-1597-1876

Dr. Sci. (Med.), Associate Professor, Professor of the Chair of Polyclinic Therapy and Internal Diseases

Russian Federation, Omsk

Maria Yu. Rozhkova

Omsk State Medical University

Email: dmitry_trukhan@mail.ru
ORCID iD: 0000-0002-7695-149X
Russian Federation, Omsk

Victoria V. Goloshubina

Omsk State Medical University

Email: dmitry_trukhan@mail.ru
ORCID iD: 0000-0003-1481-8842
Russian Federation, Omsk

References

  1. Трухан Д.И., Деговцов Е.Н., Дрокина О.В. Пациент с синдромом запора на амбулаторно-поликлиническом приеме: актуальные аспекты дифференциальной диагностики и лечения. Медицинский совет. 2021;5:142–53. [Trukhan D.I., Degovtsov E.N., Drokina O.V. A patient with constipation syndrome at an outpatient appointment: topical aspects of differential diagnosis and treatment. Meditsinskii sovet. 2021;5:142–53. (In Russ.)]. doi: 10.21518/2079-701X-2021-5-142-153.
  2. Higgins P.D., Johanson J.F. Epidemiology of constipation in North America: A systematic review. Am J Gastroenterol. 2004;99:750–59. doi: 10.1111/j.1572-0241.2004.04114.x.
  3. Wald A., Scarpignato C., Mueller-Lissner S., et al. A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther. 2008;28:917–30. doi: 10.1111/j.1365-2036.2008.03806.x.
  4. Tack J., Muller-Lissner S. Treatment of chronic constipation: Current pharmacologic approaches and future directions. Clin Gastroenterol Hepatol. 2009;7:502–8. 496. quiz. doi: 10.1016/j.cgh.2008.12.006.
  5. Ebling B., Gulic S., Jurcic D., et al. Demographic, anthropometric and socioeconomic characteristics of functional constipation in Eastern Croatia. Coll Antropol. 2014;38(2):539–46.
  6. Трухан Д.И., Филимонов С.Н. Дифференциальный диагноз основных гастроэнтерологических синдромов и симптомов. М.: Практическая медицина. 2016. 168 с. [Trukhan D.I., Filimonov S.N. Differential diagnosis of the main gastroenterological syndromes and symptoms. Moscow: Practical medicine. 2016. 168 p. (In Russ.)].
  7. Парфенов А.И., Индейкина Л.Х., Беляева А.А. и др. Хронический запор. Методические рекомендации. М., 2016. 54 с. [Parfenov A.I., Indeikina L.Kh., Belyaeva A.A. etc. Chronic constipation. Guidelines. M., 2016. 54 p. (In Russ.)].
  8. Лазебник Л. Б., Туркина С. В., Голованова Е.В. и др. Запоры у взрослых. Экспериментальная и клиническая гастроэнтерология. 2020;175(3):10–33. [Lazebnik L.B., Turkina S.V., Golovanova E.V. et al. Constipation in adults. Experimental and clinical gastroenterology. 2020;175(3): 10–33. (In Russ.)]. doi: 10.31146/1682-8658-ecg-175-3-10-33.
  9. Трухан Д.И., Филимонов С.Н. Дифференциальный диагноз основных симптомов и синдромов при заболеваниях желудочно-кишечного тракта: учебное пособие Новокузнецк: Полиграфист, 2022. 234 с. [Trukhan D.I., Filimonov S.N. Differential diagnosis of the main symptoms and syndromes in diseases of the gastrointestinal tract: textbook Novokuznetsk: Polygraphist, 2022. 234 p. (In Russ.)].
  10. Тарасова Л.В., Трухан Д.И. Болезни кишечника. Клиника, диагностика и лечение. СПб.: СпецЛит, 2022. 222 с. [Tarasova L.V., Trukhan D.I. Diseases of the intestines. Clinic, diagnosis and treatment. St. Petersburg: SpecLit, 2022. 222 p. (In Russ.)].
  11. Irvine E.J., Ferrazzi S., Pare P., et al. Health-related quality of life in functional GI disorders: Focus on constipation and resource utilization. Am J Gastroenterol. 2002;97:1986–83. doi: 10.1111/j.1572-0241.2002.05843.x.
  12. Drossman D.A., Hasler W.L. Rome IV – Functional GI disorders: disorders of Gut-Brain interaction. Gastroenterology 2016;150(6):1257–61. doi: 10.1053/j.gastro.2016.03.035.
  13. Lacy B.E., Patel N.K. Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. J Clin Med. 2017;6(11). pii: E99. doi: 10.3390/jcm6110099.
  14. Шемеровский К.А. Проблема запора: хронофизиологический подход. Врач. 2011;10:19–24. [Shemerovsky K.A. The problem of constipation: a chronophysiological approach. Vrach. 2011;10:19–24. (In Russ.)].
  15. Шемеровский К.А., Селиверстов П.В., Бочкарёв М.В., Шайдуллина С.Р. Хронофизиологический механизм регулярности циркадианного ритма эвакуаторной функции кишечника. Экспериментальная и клиническая гастроэнтерология. 2019;5:150–153. [Shemerovsky K.A., Seliverstov P.V., Bochkarev M.V., Shaydullina S.R. Chronophysiological mechanism of the regularity of the circadian rhythm of the intestinal evacuation function. Eksperimental’naya i klinicheskaya gastroenterologiya. 2019;5:150–153. (In Russ.)]. doi: 10.31146/1682-8658-ecg-165-5-150-153.
  16. Шемеровский К.А., Селивёрстов П.В. Синдром брадиэнтерии в клинике внутренних болезней. Экспериментальная и клиническая гастроэнтерология. 2021;196(12):53–61. [Shemerov- sky K.A., Seliverstov P.V. Bradyenteria syndrome in the clinic of internal diseases. Eksperimental’naya i klinicheskaya gastroenterologiya. 2021;196(12):53–61. (In Russ.)]. doi: 10.31146/1682-8658-ecg.
  17. Koppen I.J.N., Benninga MA. Functional Constipation and Dyssynergic Defecation in Children. Front Pediatr. 2022;1.0:832877. doi: 10.3389/fped.2022.832877.
  18. Sharma A., Herekar A., Yan Y., Karunaratne T., Rao SSC. Dyssynergic Defecation and Other Evacuation Disorders. Gastroenterol Clin North Am. 2022;51(1):55–69. doi: 10.1016/j.gtc.2021.10.004.
  19. Rao S.S.C., Lacy B.E., Emmanuel A., et al. Recognizing and Defining Occasional Constipation: Expert Consensus Recommendations. Am J Gastroenterol. 2022;117(11):1753–58. doi: 10.14309/ajg.0000000000001945.
  20. Wald A., Scarpignato C., Mueller-Lissner S., et al. A multinational survey of prevalence and patterns of laxative use among adults with self-defined constipation. Aliment Pharmacol Ther. 2008;28:917–30. doi: 10.1111/j.1365-2036.2008.03806.x.
  21. Mugie S.M., Benninga M.A., Di Lorenzo C. Epidemiology of constipation in children and adults: A systematic review. Best Pract Res Clin Gastroenterol. 2011;25:3–18. doi: 10.1016/j.bpg.2010.12.010.
  22. Suares N.C., Ford A.C. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: Systematic review and meta-analysis. Am J Gastroenterol. 2011;106:1582–91. doi: 10.1038/ajg.2011.164.
  23. Zeitoun J.D., de Parades V. Chronic constipation in adults. Presse Med. 2013;42:1176–85. doi: 10.1016/j.lpm.2012.09.034.
  24. Sperber A.D., Bangdiwala S.I., Drossman D.A., et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160(1):99–114.e3. doi: 10.1053/j.gastro.2020.04.014.
  25. Кузнецова И.В., Успенская Ю.Б. Особенности заболеваний кишечника у женщин. Фарматека. 2013;18:72–8. [Kuznetsova I.V., Uspenskaya Yu.B. Features of intestinal diseases in women. Farmateka. 2013;18:72–8. (In Russ.)].
  26. Zhao Y.F., Ma X.Q., Wang R., et al. Epidemiology of functional constipation and comparison with constipation-predominant irritable bowel syndrome: the Systematic Investigation of Gastrointestinal Diseases in China (SILC). Aliment Pharmacol Ther. 2011;34(8):1020–29. doi: 10.1111/j.1365-2036.2011.04809.x.
  27. Liu L.W. Chronic constipation: current treatment options. Can J Gastroenterol. 2011;25 Suppl B(Suppl B):22B–28B.
  28. Olaru C., Diaconescu S., Trandafir L., et al. Some Risk Factors of Chronic Functional Constipation Identified in a Pediatric Population Sample from Romania. Gastroenterol Res Pract. 2016;2016:3989721. doi: 10.1155/2016/3989721.
  29. Velasco-Benitez C.A., Collazos-Saa L.I., Garcia-Perdomo H.A. A systematic review and meta-analysis in schoolchildren and adolescents with functional gastrointestinal disorders according to Rome IV criteria. Arq Gastroenterol. 2022;59(2):304–13. doi: 10.1590/S0004-2803.202202000-53.
  30. Murakami K., Sasaki S., Okubo H., et al. Association between dietary fiber, water and magnesium intake and functional constipation among young Japanese women. Eur J Clin Nutr. 2006;61:616–22. doi: 10.1038/sj.ejcn.1602573.
  31. Трухан Д.И., Филимонов С.Н. Заболевания кишечника: клиника, диагностика и лечение. Новокузнецк: ООО «Полиграфист». 2017. 223 с. [Trukhan D.I., Filimonov S.N. Intestinal diseases: clinic, diagnosis and treatment. Novokuznetsk: Polygraphist LLC, 2017. 223 p. (In Russ.)].
  32. Трухан Д.И. Дифференциальная диагностика запора. Справочник поликлинического врача. 2016;2:4–7. [Trukhan D.I. Differential diagnosis of constipation. Spravochnik poliklinicheskogo vracha. 2016;2:4–7. (In Russ.)].
  33. Rollet M., Bohn T., Vahid F. On Behalf Of The Oriscav Working Group. Association between Dietary Factors and Constipation in Adults Living in Luxembourg and Taking Part in the ORISCAV-LUX 2 Survey. Nutrients. 2021;14(1):122. doi: 10.3390/nu14010122.
  34. Okawa Y., Fukudo S., Sanada H. Specific foods can reduce symptoms of irritable bowel syndrome and functional constipation: a review. Biopsychosoc Med. 2019;13:10. doi: 10.1186/s13030-019-0152-5.
  35. Schnabel L., Buscail C., Sabate J.M., et al. Association Between Ultra-Processed Food Consumption and Functional Gastrointestinal Disorders: Results From the French NutriNet-Sante Cohort. Am J Gastroenterol. 2018;113(8):1217–28. doi: 10.1038/s41395-018-0137-1.
  36. Vasseur P., Dugelay E., Benamouzig R., et al. Dietary Patterns, Ultra-processed Food, and the Risk of Inflammatory Bowel Diseases in the NutriNet-Sante Cohort. InflammBowel Dis. 2021;27(1):65–73. doi: 10.1093/ibd/izaa018.
  37. Деговцов Е.Н., Трухан Д.И., Никоненко В.А., Косенок В.И. Синдром запора в хирургической практике: актуальные аспекты диагностики и лечения. Стационарозамещающие технологии: Амбулаторная хирургия. 2020;(1–2):46–56. [Degovtsov E.N., Trukhan D.I., Nikonenko V.A., Kosenok V.I. Constipation syndrome in surgical practice: topical aspects of diagnosis and treatment. Stationary-replacing technologies: Ambulatory surgery. 2020;(1–2):46–56. (In Russ.)]. doi: 10.21518/1995-1477-2020-1-2-46-56.
  38. Markland A.D., Palsson O., Goode P.S., et al. Association of low dietary intake of fiber and liquids with constipation: Evidence from the national health and nutrition examination survey. Am J Gastroenterol. 2013;108:796–803. doi: 10.1038/ajg.2013.73.
  39. Gilca-Blanariu G.E., Trifan A., Ciocoiu M., et al. Magnesium-A Potential Key Player in Inflammatory Bowel Diseases? Nutrients. 2022;14(9):1914. doi: 10.3390/nu14091914.
  40. Гриневич В.Б., Губонина И.В., Дощицин В.Л. и др. Особенности ведения коморбидных пациентов в период пандемии новой коронавирусной инфекции (COVID-19). Национальный Консенсус 2020. Кардиоваскулярная терапия и профилактика. 2020; 19 (4): 135-172. [Grinevich V.B., Gubonina I.V., Doshchitsin V.L. et. al. Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020. Kardiovaskulyarnaya terapiya i profilaktika. 2020;19(4):135–72. (In Russ.)]. doi: 10.15829/1728-88002020- 2630.
  41. Masir M.N., Shirvaliloo M. Symptomatology and microbiology of the gastrointestinal tract in post-COVID conditions. JGH Open. 2022;6(10):667–76. doi: 10.1002/jgh3.12811.
  42. Freedberg D.E., Chang L. Gastrointestinal symptoms in COVID-19: the long and the short of it. Curr Opin Gastroenterol. 2022;38(6):555–61. doi: 10.1097/MOG.0000000000000876.
  43. Тарасова Л.В., Трухан Д.И. Болезни кишечника. Клиника, диагностика и лечение СПб.: СпецЛит, 2013. 144 с. [Tarasova L.V., Trukhan D.I. Diseases of the intestines. Clinic, diagnosis and treatment St. Petersburg: SpetsLit, 2013. 144 p. (In Russ.)].
  44. Honkura K., Tomata Y., Sugiyama K., et al. Defecation frequency and cardiovascular disease mortality in Japan: The Ohsaki cohort study. Atherosclerosis. 2016;246:251–56. doi: 10.1016/j.atherosclerosis.2016.01.007.
  45. Sundboll J., Szepligeti S.K., Adelborg K., et al. Constipation and risk of cardiovascular diseases: a Danish population-based matched cohort study. BMJ Open. 2020;10(9):e037080. doi: 10.1136/bmjopen-2020-037080.
  46. Sumida K., Molnar M.Z., Potukuchi P.K., et al. Constipation and risk of death and cardiovascular events. Atherosclerosis. 2019;281:114–20. doi: 10.1016/j.atherosclerosis.2018.12.021.
  47. Ивашкин В.Т., Шелыгин Ю.А., Маев И.В., Шептулин А.А., Алешин Д.В. и др. Диагностика и лечение запора у взрослых (Клинические рекомендации Российской гастроэнтерологической ассоциации и Ассоциации колопроктологов России). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2020;30(6):69–85. [Ivashkin V.T., Shely- gin Yu.A., Maev I.V., Sheptulin A.A., Aleshin D.V. Diagnosis and treatment of constipation in adults (Clinical recommendations of the Russian Gastroenterological Association and the Association of Coloproctologists of Russia). Rossiiskii zhurnal gastroenterologii, gepatologii, koloproktologii. 2020;30(6):69–85. (In Russ.)]. doi: 10.22416/1382-4376-2020-30- 6-69-85.
  48. Трухан Д.И. Функциональные гастроинтестинальные расстройства: перспективы использования лечебной минеральной воды. Медицинский совет. 2017;5:70–6. [Trukhan D.I. Functional gastrointestinal disorders: prospects for the use of therapeutic mineral water. Meditsinskii sovet. 2017;5:70–6. (In Russ.)]. doi: 10.21518/2079-701X-2017-5-70-76.
  49. Ефименко Н.В. Механизмы действия питьевых минеральных вод и их роль в курортной гастроэнтерологии. Курортная медицина. 2015;3:2–7. [Efimenko N.V. Mechanisms of action of drinking mineral waters and their role in resort gastroenterology. Spa medicine. 2015;3:2–7. Efimenko N.V. Mechanisms of action of drinking mineral waters and their role in resort gastroenterology. Kurortnaya meditsina. 2015;3:2–7.
  50. Филимонов Р.М., Герасименко М.Ю. Минеральная вода как важный фактор нутритивной поддержки гомеостаза организма. Экспериментальная и клиническая гастроэнтерология. 2015;8:21–4. [Filimonov R.M., Gerasimenko M.Yu. Mineral water as an important factor in the nutritional support of body homeostasis. Eksperimental’naya i klinicheskaya gastroenterologiya. 2015;8:21–4. (In Russ.)].
  51. Фролков В.К. Новые представления о механизмах лечебно-профилактического действия питьевых минеральных вод. Клиническая медицина и фармакология. 2015;4:34–6. [Frolkov V.K. New ideas about the mechanisms of therapeutic and prophylactic action of drinking mineral waters. Klinicheskaya meditsina i farmakologiya. 2015;4:34–6. (In Russ.)].
  52. Fornai M., Colucci R., Antonioli L., et al. Effects of a bicarbonate-alkaline mineral water on digestive motility in experimental models of functional and inflammatory gastrointestinal disorders. Methods Find Exp Clin Pharmacol. 2008;30(4):261–69. doi: 10.1358/mf.2008.30.4.1159650.
  53. Fraioli A., Menunni G., Petraccia L., et al. Sulphate-bicarbonate mineral waters in the treatment of biliary and digestive tract diseases. Clin Ter. 2010;161(2):163–68.
  54. Dupont C., Campagne A., Constant F. Efficacy and safety of a magnesium sulfate-rich natural mineral water for patients with functional constipation. Clin Gastroenterol Hepatol. 2014;12(8):1280–87. doi: 10.1016/j.cgh.2013.12.005.
  55. Кручинина М.А., Пюрвеева К.В., Минушкин О.Н., Львова Н.В. Опыт применения минеральной воды «Донат Mg» в гастроэнтерологической практике. Медицинский совет. 2017;15: 92–6. [Kruchinina M.A., Pyurveeva K.V., Minushkin O.N., Lvova N.V. Experience in the use of Donat Mg mineral water in gastroenterological practice. Meditsinskii sovet. 2017;15:92–6. (In Russ.)]. doi: 10.21518/2079-701X-2017-15-92-96.
  56. Погорелова А.С. Роль минеральной воды «Донат Mg» в терапевтической практике. Медицинский совет. 2017;3:99–102. [Pogorelova A.S. The role of Donat Mg mineral water in therapeutic practice. Meditsinskii sovet. 2017;3:99–102. (In Russ.)]. doi: 10.21518/2079-701X-2017-3-99-102.
  57. Куликов А.Г., Захарова И.Н., Творогова Т.М., Степурина Л.Л., Елезова Л.И. Применение магнийсодержащих минеральных вод при функциональных запорах у детей и подростков. Физиотерапия, бальнеология и реабилитация. 2018;5:272–278. [Kulikov A.G., Zakharova I.N., Tvorogova T.M., Stepurina L.L., Elezova L.I. The use of magnesium-containing mineral waters for functional constipation in children and adolescents. Fizioterapiya, bal’neologiya i reabilitatsiya. 2018;5:272–278. (In Russ.)]. doi: 10.17816/1681-3456-2018-17- 5-272-278.
  58. Степурина Л.Л., Куликов А.Г., Захарова И.Н., Творогова Т.М., Елезова Л.И. Применение магнийсодержащих минеральных вод при функциональных запорах у детей и подростков. Вестник физиотерапии и курортологии. 2019;4:101–6. [Stepurina L.L., Kulikov A.G., Zakharova I.N., Tvorogova T.M., Elezova L.I. The use of magnesium-containing mineral waters for functional constipation in children and adolescents. Vestnik fizioterapii i kurortologii. 2019;4:101–6. (In Russ.)].
  59. Dupont C, Hebert G. Magnesium Sulfate-Rich Natural Mineral Waters in the Treatment of Functional Constipation-A Review. Nutrients. 2020;12(7):2052. doi: 10.3390/nu12072052.
  60. Constant F., Morali A., Arnaud M.J., et al. Treatment of idiopathic constipation in infants: Comparative and randomized study of two mineral waters (60 cases) J Pediatr Gastroenterol Nutr. 1999;28:551. doi: 10.1097/00005176-199905000-00052
  61. Dupont C., Campagne A., Constant F. Efficacy and safety of a magnesium sulfate-rich natural mineral water for patients with functional constipation. Clin Gastroenterol Hepatol. 2014;12:1280–87. doi: 10.1016/j.cgh.2013.12.005.
  62. Dupont C., Constant F., Imbert A., et al. Time to treatment response of a magnesium- and sulphate-rich natural mineral water in functional constipation. Nutrition. 2019;65:167–72. doi: 10.1016/j.nut.2019.02.018.
  63. Naumann J., Sadaghiani C.D., Alt F., Huber R. Effects of Sulfate-Rich Mineral Water on Functional Constipation: A Double-Blind, Randomized, Placebo-Controlled Study. Complement. Med Res. 2016;23:356–63. doi: 10.1159/000449436.
  64. Bothe G., Coh A., Auinger A. Efficacy and safety of a natural mineral water rich in magnesium and sulphate for bowel function: A double-blind, randomized, placebo-controlled study. Eur J Nutr. 2015;56:491–99. doi: 10.1007/s00394-015-1094-8.
  65. Боте Г., Чох А., Ауингер А. Эффективность и безопасность природной минеральной воды, богатой магнием и сульфатами, для функции кишечника. Рандомизированное плацебо-контролируемое двойное слепое исследование. Медицинский совет. 2016;14:100–8. [Bothe G., Choh A, Auinger A. Efficacy and safety of natural mineral water rich in magnesium and sulfates for bowel function. Randomized, placebo-controlled, double-blind study. Meditsinskii sovet.2016;14:100–8. (In Russ.)]. doi: 10.21518/2079-701X-2016-14-100-108.
  66. Захарова И.Н., Творогова Т.М., Мумладзе Э.Б. и др. Лечебная минеральная вода: от прошлого к будущему. Медицинский совет. 2015;14:106–13. [Zakharova I.N., Tvorogova T.M., Mumladze E.B. et al. Medical mineral water: from the past to the future. Meditsinskii sovet.2015;14:106–13. (In Russ.)].
  67. Luft F.C., Zemel M.B., Sowers J.A., et al. Sodium bicarbonate and sodium chloride: effects on blood pressure and electrolyte homeostasis in normal and hypertensive man. J Hypertens. 1990;8(7):663–70. doi: 10.1097/00004872-199007000-00010.
  68. Petraccia L., Liberati G., Masciullo S.G., et al. Water, mineral waters and health. Clin Nutr. 2006;25(3):377–85. doi: 10.1016/j.clnu.2005.10.002.
  69. Quattrini S., Pampaloni B., Brandi M.L. Natural mineral waters: chemical characteristics and health effects. Clin Cases Miner Bone Metab. 2016;13(3):173–80. doi: 10.11138/ccmbm/2016.13.3.173.
  70. Drossman D.A. The Functional Gastrointestinal Disorders and the Rome III Process. Gastroenterology. 2006;130(5):1377–90. doi: 10.1053/j.gastro.2006.03.008.
  71. Коровина Н.А., Захарова И.Н., Гаврюшова Л.П. и др. Применение минеральной воды «Донат Mg» при соматической патологии у детей. Пособие для практикующих врачей-педиатров. М., 2005. 60 с. [Korovina N.A., Zakharova I.N., Gavryushova L.P. et al. The use of mineral water «Donat Mg» in somatic pathology in children. Handbook for practicing pediatricians. M., 2005. 60 p. (In Russ.)].
  72. Захарова И.Н., Елезова Л.И., Степурина Л.Л. и др. Применение природной минеральной воды, обогащенной магнием, при лечении запоров у детей. Вопросы современной педиатрии. 2013;12(3):56-63. [Zakharova I.N., Elezova L.I., Stepurina L.L. et al. The use of natural mineral water enriched with magnesium in the treatment of constipation in children. Voprosy sovremennoi pediatrii. 2013;12(3):56-63. (In Russ.)].
  73. Эфендиева М.Т., Бадшиева В.А., Русенко Н.И. Магнийсодержащие минеральные воды в лечении больных с кардиальными проявлениями гастроэзофагеальной рефлюксной болезнью. Вопросы курортологии, физиотерапии и лечебной физкультуры. 2006;6:31–3. [Efendieva M.T., Badshieva V.A., Rusenko N.I. Magnesium-containing mineral waters in the treatment of patients with cardiac manifestations of gastroesophageal reflux disease. Voprosy kurortologii, fizioterapii i lechebnoi fizkul’tury. 2006;6:31–3. (In Russ.)].
  74. Захарова И.Н., Куликов А.Г., Османов И.М. и др. Функциональный запор у детей: современные критерии диагностики и подходы к лечению. Consilium Medicum. 2018;2:51–7. [Zakharova I.N., Kulikov A.G., Osmanov I.M. et al. Functional constipation in children: modern diagnostic criteria and approaches to treatment. Consilium Medicum. 2018;2:51–7. (In Russ.)]. doi: 10.26442/2413-8460_2018.2.51-57.
  75. Фролков В.К. Механизмы влияния «Донат Mg» на обмен веществ и заболевания желудочно-кишечного тракта. [Frolkov V.K. Mechanisms of influence of «Donat Mg» on metabolism and diseases of the gastrointestinal tract. (In Russ.)]. URL: http://donatmg.ru/issledov/klinika/2009/09/29/ klinika_13.html
  76. Фролков В.К. Влияние «Донат Mg» на резистентность слизистой желудка при действии стрессорных факторов. [Frolkov V.K. Influence of «Donat Mg» on the resistance of the gastric mucosa under the action of stress factors. (In Russ.)]. URL: http://donatmg.ru/issledov/klinika/ 2009/09/29/klinika_12.html
  77. Балаболкин М.И. Изучение влияния «Донат Mg» на состояние больных инсулинонезависимым сахарным диабетом. [Balabolkin M.I. Study of the effect of «Donat Mg» on the condition of patients with non-insulin-dependent diabetes mellitus. (In Russ.)]. URL: http://donatmg.ru/issledov/klinika/2009/09/29/klinika_17.html

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies